The following stories appear in full on Today's Vidyya Medical News Service Web site.
Researchers at the National Institute of Child Health and Human Development (NICHD) are recruiting women who have premature ovarian failure formerly known as premature menopause to determine if restoring testosterone will help prevent osteoporosis.
For more information: Researchers Seek Women With Premature Ovarian Failure For Testosterone Replacement Study
A generation ago, it was suggested that the time had come to "close the book" on infectious diseases. With the availability of a growing arsenal of antibiotics and vaccines, some policymakers argued that biomedical research resources should be diverted from infectious diseases to other concerns. Today, the folly of this position is clear: infectious diseases are the second leading cause of death and the leading cause of disability-adjusted life years worldwide (one disability-adjusted life year is one lost year of healthy life).
For more information: Fauci Presents Roadmap For Infectious Disease Research In 21st Century
United Therapeutics Corporation announced today that it has completed enrollment in its phase III study of oral beraprost in patients with pulmonary hypertension. Approximately 116 patients in ten centers in the United States were randomized into the double-blind, placebo-controlled study in patients with moderate pulmonary hypertension.
For more information: The National Cancer Institute Publishes Atlas Of Cancer Mortality
This patient handout explains that like all sexual activity, oral sex carries some risk, particularly when one partner or the other is known to be infected with HIV, when either partnerís HIV status is not known, and/or when one or the other partner is not monogamous or injects drugs. Numerous studies have demonstrated that oral sex can result in the transmission of HIV and other sexually transmitted diseases (STDs). Abstaining from oral, anal, and vaginal sex all together or having sex only with a mutually monogamous, uninfected partner are the only ways that individuals can be completely protected from the sexual transmission of HIV.
For more information: United Therapeutics Completes Enrollment In Phase III Study Of First Oral Therapy For Early-Stage Pulmonary Hypertension
Although this certainly will not be the first AIDS vaccine to enter human trials, Merck's testing of a new vaccine appears promising.
For more information: Information For Professionals: Primary Pulmonary Hypertension
Today's Vidyya articles are:
As always, we hope you enjoy the issue.